Docusign’s (DOCU) Market Outperform Rating Reiterated at JMP Securities

JMP Securities restated their market outperform rating on shares of Docusign (NASDAQ:DOCU) in a research report sent to investors on Friday,Benzinga reports. They currently have a $124.00 price target on the stock.

Several other brokerages also recently issued reports on DOCU. Wells Fargo & Company upped their price objective on Docusign from $80.00 to $85.00 and gave the company an “equal weight” rating in a research report on Friday, September 5th. Robert W. Baird boosted their target price on shares of Docusign from $85.00 to $90.00 and gave the company a “neutral” rating in a research note on Friday, September 5th. Wall Street Zen raised shares of Docusign from a “hold” rating to a “buy” rating in a research note on Saturday, September 13th. Royal Bank Of Canada lifted their price target on shares of Docusign from $90.00 to $95.00 and gave the stock a “sector perform” rating in a report on Friday, September 5th. Finally, JPMorgan Chase & Co. upped their price objective on shares of Docusign from $77.00 to $80.00 and gave the company a “neutral” rating in a research note on Friday, September 5th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and fifteen have issued a Hold rating to the stock. Based on data from MarketBeat, Docusign currently has an average rating of “Hold” and a consensus price target of $94.14.

Docusign Price Performance

DOCU stock opened at $69.73 on Friday. The company’s 50 day simple moving average is $76.17 and its 200-day simple moving average is $79.00. Docusign has a 12 month low of $62.66 and a 12 month high of $107.86. The firm has a market capitalization of $14.02 billion, a PE ratio of 52.43, a P/E/G ratio of 3.47 and a beta of 1.02.

Docusign (NASDAQ:DOCU) last issued its quarterly earnings data on Thursday, September 4th. The company reported $0.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.84 by $0.08. The firm had revenue of $800.64 million during the quarter, compared to the consensus estimate of $780.35 million. Docusign had a return on equity of 14.01% and a net margin of 9.08%.The company’s quarterly revenue was up 8.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.97 EPS. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. As a group, sell-side analysts anticipate that Docusign will post 1.17 earnings per share for the current year.

Insider Buying and Selling

In other Docusign news, insider Robert Chatwani sold 13,817 shares of the business’s stock in a transaction dated Wednesday, September 17th. The stock was sold at an average price of $83.10, for a total transaction of $1,148,192.70. Following the transaction, the insider owned 71,162 shares in the company, valued at $5,913,562.20. The trade was a 16.26% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Peter Solvik sold 15,000 shares of the company’s stock in a transaction dated Monday, September 15th. The stock was sold at an average price of $81.48, for a total value of $1,222,200.00. Following the completion of the sale, the director directly owned 135,253 shares of the company’s stock, valued at $11,020,414.44. The trade was a 9.98% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 96,533 shares of company stock valued at $7,281,953 over the last ninety days. Insiders own 1.66% of the company’s stock.

Institutional Trading of Docusign

Hedge funds have recently made changes to their positions in the company. Banque Transatlantique SA acquired a new position in shares of Docusign during the first quarter worth $26,000. Hemington Wealth Management increased its stake in Docusign by 318.1% during the 1st quarter. Hemington Wealth Management now owns 347 shares of the company’s stock worth $28,000 after buying an additional 264 shares during the period. Golden State Wealth Management LLC lifted its holdings in Docusign by 519.4% in the 1st quarter. Golden State Wealth Management LLC now owns 384 shares of the company’s stock worth $31,000 after buying an additional 322 shares in the last quarter. Summit Securities Group LLC purchased a new position in Docusign in the 1st quarter valued at about $34,000. Finally, Rise Advisors LLC boosted its position in Docusign by 864.6% in the 1st quarter. Rise Advisors LLC now owns 463 shares of the company’s stock valued at $38,000 after buying an additional 415 shares during the last quarter. Hedge funds and other institutional investors own 77.64% of the company’s stock.

Docusign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.